Nucleation of protein fibrillation by nanoparticles
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Nanoparticles present enormous surface areas and are found to enhance the rate of protein fibrillation by decreasing the lag time for nucleation. Protein fibrillation is involved in many human diseases, including Alzheimer's, Creutzfeld-Jacob disease, and dialysis-related amyloidosis. Fibril formation occurs by nucleation-dependent kinetics, wherein formation of a critical nucleus is the key rate-determining step, after which fibrillation proceeds rapidly. We show that nanoparticles (copolymer particles, cerium oxide particles, quantum dots, and carbon nanotubes) enhance the probability of appearance of a critical nucleus for nucleation of protein fibrils from human β 2 -microglobulin. The observed shorter lag (nucleation) phase depends on the amount and nature of particle surface. There is an exchange of protein between solution and nanoparticle surface, and β 2 -microglobulin forms multiple layers on the particle surface, providing a locally increased protein concentration promoting oligomer formation. This and the shortened lag phase suggest a mechanism involving surface-assisted nucleation that may increase the risk for toxic cluster and amyloid formation. It also opens the door to new routes for the controlled self-assembly of proteins and peptides into novel nanomaterials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MOLMOL: A program for display and analysis of macromolecular structures
Koradi, R., Billeter, M., & Wüthrich, K. (1996) · Journal of Molecular Graphics · doi:10.1016/0263-7855(96)00009-4 · Cited by 7,163
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,423
Cedervall, T., Lynch, I., Lindman, S., Berggård, T., Thulin, E., Nilsson, H., Dawson, K. A., & Linse, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608582104 · Cited by 3,281
Self-citationTranslocation of inhaled ultrafine particles to the brain
Oberdörster, G., Sharp, Z., Atudorei, V., Elder, A., Gelein, R., Kreyling, W., & Cox, C. (2004) · Inhalation Toxicology · doi:10.1080/08958370490439597 · Cited by 2,606
The potential environmental impact of engineered nanomaterials
Colvin, V. L. (2003) · Nature Biotechnology · doi:10.1038/nbt875 · Cited by 2,158
Xia, T., Kovochich, M., Brant, J., Hotze, M., Sempf, J., Oberley, T., Sioutas, C., Yeh, J. I., Wiesner, M. R., & Nel, A. E. (2006) · Nano Letters · doi:10.1021/nl061025k · Cited by 1,918
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2005) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,687
Equilibrium cluster formation in concentrated protein solutions and colloids
Stradner, A., Sedgwick, H., Cardinaux, F., Poon, W. C. K., Egelhaaf, S. U., & Schurtenberger, P. (2004) · Nature · doi:10.1038/nature03109 · Cited by 1,070
Gejyo, F., Yamada, T., Odani, S., Nakagawa, Y., Arakawa, M., Kunitomo, T., Kataoka, H., Suzuki, M., Hirasawa, Y., Shirahama, T., et al. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)91948-5 · Cited by 980
Probing BSA Binding to Citrate-Coated Gold Nanoparticles and Surfaces
Brewer, S. H., Glomm, W. R., Johnson, M. C., Knag, M. K., & Franzen, S. (2005) · Langmuir · doi:10.1021/la050588t · Cited by 892
Cited by
Understanding biophysicochemical interactions at the nano–bio interface
Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083
Silver nanoparticles: Green synthesis and their antimicrobial activities
Sharma, V. K., Yngard, R. A., & Lin, Y. (2009) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2008.09.002 · Cited by 3,900
Biomolecular coronas provide the biological identity of nanosized materials
Monopoli, M. P., Åberg, C., Salvati, A., & Dawson, K. A. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.207 · Cited by 3,017
Self-citationThe role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles
Fröhlich, E. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s36111 · Cited by 2,484
Xia, T., Kovochich, M., Liong, M., Mädler, L., Gilbert, B., Shi, H., Yeh, J. I., Zink, J. I., & Nel, A. E. (2008) · ACS Nano · doi:10.1021/nn800511k · Cited by 2,469
De Greef, T. F. A., Smulders, M. M. J., Wolffs, M., Schenning, A. P. H. J., Sijbesma, R. P., & Meijer, E. W. (2009) · Chemical Reviews · doi:10.1021/cr900181u · Cited by 2,459
Monopoli, M. P., Walczyk, D., Campbell, A., Elia, G., Lynch, I., Baldelli Bombelli, F., & Dawson, K. A. (2011) · Journal of the American Chemical Society · doi:10.1021/ja107583h · Cited by 1,835
Self-citationAggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., & McNeil, S. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.009 · Cited by 1,791
Protein-nanoparticle interactions
Lynch, I., & Dawson, K. A. (2008) · Nano Today · doi:10.1016/s1748-0132(08)70014-8 · Cited by 1,727
Self-citationProtein−Nanoparticle Interactions: Opportunities and Challenges
Mahmoudi, M., Lynch, I., Ejtehadi, M. R., Monopoli, M. P., Bombelli, F. B., & Laurent, S. (2011) · Chemical Reviews · doi:10.1021/cr100440g · Cited by 1,426
Self-citationDependence of Nanoparticle Toxicity on Their Physical and Chemical Properties
Sukhanova, A., Bozrova, S., Sokolov, P., Berestovoy, M., Karaulov, A., & Nabiev, I. (2018) · Nanoscale Research Letters · doi:10.1186/s11671-018-2457-x · Cited by 1,107
Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle
Saptarshi, S. R., Duschl, A., & Lopata, A. L. (2013) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-11-26 · Cited by 1,079
Reidy, B., Haase, A., Luch, A., Dawson, K., & Lynch, I. (2013) · Materials · doi:10.3390/ma6062295 · Cited by 1,035
Self-citationInteraction of Gold Nanoparticles with Common Human Blood Proteins
Lacerda, S. H. D. P., Park, J. J., Meuse, C., Pristinski, D., Becker, M. L., Karim, A., & Douglas, J. F. (2010) · ACS Nano · doi:10.1021/nn9011187 · Cited by 976
Binding of blood proteins to carbon nanotubes reduces cytotoxicity
Ge, C., Du, J., Zhao, L., Wang, L., Liu, Y., Li, D., Yang, Y., Zhou, R., Zhao, Y., Chai, Z., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105270108 · Cited by 940
Calderón-Garcidueñas, L., Solt, A. C., Henríquez-Roldán, C., Torres-Jardón, R., Nuse, B., Herritt, L., Villarreal-Calderón, R., Osnaya, N., Stone, I., García, R., et al. (2008) · Toxicologic Pathology · doi:10.1177/0192623307313011 · Cited by 937
Canton, I., & Battaglia, G. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15309b · Cited by 936
The ecotoxicology and chemistry of manufactured nanoparticles
Handy, R. D., von der Kammer, F., Lead, J. R., Hassellöv, M., Owen, R., & Crane, M. (2008) · Ecotoxicology · doi:10.1007/s10646-008-0199-8 · Cited by 916
Self-assembling peptide and protein amyloids: from structure to tailored function in nanotechnology
Wei, G., Su, Z., Reynolds, N. P., Arosio, P., Hamley, I. W., Gazit, E., & Mezzenga, R. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00542j · Cited by 904
Elsaesser, A., & Howard, C. V. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.09.001 · Cited by 895
Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation
Deng, Z. J., Liang, M., Monteiro, M., Toth, I., & Minchin, R. F. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2010.250 · Cited by 893
Crossing the blood-brain barrier with nanoparticles
Zhou, Y., Peng, Z., Seven, E. S., & Leblanc, R. M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.015 · Cited by 837
“However, after the initial observation of Linse and coworkers about the fibril formations [44] there has been studies that showed that some types of NPs can have therapeutic effects rather than induction of the neurodegenerative diseases.”
BackgroundDetailed Identification of Plasma Proteins Adsorbed on Copolymer Nanoparticles
Cedervall, T., Lynch, I., Foy, M., Berggård, T., Donnelly, S. C., Cagney, G., Linse, S., & Dawson, K. A. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200700465 · Cited by 777
Self-citationOn the lag phase in amyloid fibril formation
Arosio, P., Knowles, T. P. J., & Linse, S. (2015) · Physical Chemistry Chemical Physics · doi:10.1039/c4cp05563b · Cited by 766
Self-citationMolecular toxicity mechanism of nanosilver
McShan, D., Ray, P. C., & Yu, H. (2014) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2014.01.010 · Cited by 762
The Adverse Effects of Air Pollution on the Nervous System
Genc, S., Zadeoglulari, Z., Fuss, S. H., & Genc, K. (2012) · Journal of Toxicology · doi:10.1155/2012/782462 · Cited by 717
The nanoparticle biomolecule corona: lessons learned – challenge accepted?
Docter, D., Westmeier, D., Markiewicz, M., Stolte, S., Knauer, S. K., & Stauber, R. H. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00217f · Cited by 693
Chemical Basis of Interactions Between Engineered Nanoparticles and Biological Systems
Mu, Q., Jiang, G., Chen, L., Zhou, H., Fourches, D., Tropsha, A., & Yan, B. (2014) · Chemical Reviews · doi:10.1021/cr400295a · Cited by 679
Nguyen, P. H., Ramamoorthy, A., Sahoo, B. R., Zheng, J., Faller, P., Straub, J. E., Dominguez, L., Shea, J.-E., Dokholyan, N. V., De Simone, A., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01122 · Cited by 678
Nanomaterials in the environment: Behavior, fate, bioavailability, and effects—An updated review
Lead, J. R., Batley, G. E., Alvarez, P. J. J., Croteau, M.-N., Handy, R. D., McLaughlin, M. J., Judy, J. D., & Schirmer, K. (2018) · Environmental Toxicology and Chemistry · doi:10.1002/etc.4147 · Cited by 670
Detailed Identification of Plasma Proteins Adsorbed on Copolymer Nanoparticles
Cedervall, T., Lynch, I., Foy, M., Berggård, T., Donnelly, S. C., Cagney, G., Linse, S., & Dawson, K. A. (2007) · Angewandte Chemie · doi:10.1002/ange.200700465 · Cited by 655
Self-citationThe protein corona from nanomedicine to environmental science
Mahmoudi, M., Landry, M. P., Moore, A., & Coreas, R. (2023) · Nature Reviews Materials · doi:10.1038/s41578-023-00552-2 · Cited by 625
Xia, T., Kovochich, M., Liong, M., Zink, J. I., & Nel, A. E. (2008) · ACS Nano · doi:10.1021/nn700256c · Cited by 624
Food Chain Transport of Nanoparticles Affects Behaviour and Fat Metabolism in Fish
Cedervall, T., Hansson, L.-A., Lard, M., Frohm, B., & Linse, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032254 · Cited by 555
Self-citationInhibition of Amyloid β Protein Fibrillation by Polymeric Nanoparticles
Cabaleiro-Lago, C., Quinlan-Pluck, F., Lynch, I., Lindman, S., Minogue, A. M., Thulin, E., Walsh, D. M., Dawson, K. A., & Linse, S. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8041806 · Cited by 546
Self-citationFactors Controlling Nanoparticle Pharmacokinetics: An Integrated Analysis and Perspective
Moghimi, S. M., Hunter, A. C., & Andresen, T. L. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134623 · Cited by 545
Safety of Nanoparticles in Medicine
Wolfram, J., Zhu, M., Yang, Y., Shen, J., Gentile, E., Paolino, D., Fresta, M., Nie, G., Chen, C., Shen, H., et al. (2015) · Current Drug Targets · doi:10.2174/1389450115666140804124808 · Cited by 532
Soenen, S. J., Parak, W. J., Rejman, J., & Manshian, B. (2015) · Chemical Reviews · doi:10.1021/cr400714j · Cited by 515
Molecular Interaction of Proteins and Peptides with Nanoparticles
Shemetov, A. A., Nabiev, I., & Sukhanova, A. (2012) · ACS Nano · doi:10.1021/nn300415x · Cited by 432
Calderón-Garcidueñas, L., Franco-Lira, M., Henríquez-Roldán, C., Osnaya, N., González-Maciel, A., Reynoso-Robles, R., Villarreal-Calderon, R., Herritt, L., Brooks, D., Keefe, S., et al. (2010) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2009.02.117 · Cited by 426
Nanotechnology: History and future
Hulla, J., Sahu, S., & Hayes, A. (2015) · Human & Experimental Toxicology · doi:10.1177/0960327115603588 · Cited by 423
Hellstrand, E., Boland, B., Walsh, D. M., & Linse, S. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn900015v · Cited by 392
Self-citationFibril Fragmentation Enhances Amyloid Cytotoxicity
Xue, W.-F., Hellewell, A. L., Gosal, W. S., Homans, S. W., Hewitt, E. W., & Radford, S. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.049809 · Cited by 384
Self-citationPfeiffer, C., Rehbock, C., Hühn, D., Carrillo-Carrion, C., de Aberasturi, D. J., Merk, V., Barcikowski, S., & Parak, W. J. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2013.0931 · Cited by 378
Acceleration of α-Synuclein Aggregation by Exosomes
Grey, M., Dunning, C. J., Gaspar, R., Grey, C., Brundin, P., Sparr, E., & Linse, S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.585703 · Cited by 377
Self-citationRivera-Gil, P., Jimenez De Aberasturi, D., Wulf, V., Pelaz, B., Del Pino, P., Zhao, Y., De La Fuente, J. M., Ruiz De Larramendi, I., Rojo, T., Liang, X.-J., et al. (2013) · Accounts of Chemical Research · doi:10.1021/ar300039j · Cited by 376
Hou, K., Zhao, J., Wang, H., Li, B., Li, K., Shi, X., Wan, K., Ai, J., Lv, J., Wang, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18525-2 · Cited by 373
Nanoparticles and the Brain: Cause for Concern?
Oberdörster, G., Elder, A., & Rinderknecht, A. (2009) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2009.gr02 · Cited by 371
Patel, P. C., Giljohann, D. A., Daniel, W. L., Zheng, D., Prigodich, A. E., & Mirkin, C. A. (2010) · Bioconjugate Chemistry · doi:10.1021/bc1002423 · Cited by 366
Polymeric Delivery of Therapeutic Nucleic Acids
Kumar, R., Santa Chalarca, C. F., Bockman, M. R., Bruggen, C. V., Grimme, C. J., Dalal, R. J., Hanson, M. G., Hexum, J. K., & Reineke, T. M. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00997 · Cited by 365
Cassee, F. R., van Balen, E. C., Singh, C., Green, D., Muijser, H., Weinstein, J., & Dreher, K. (2011) · Critical Reviews in Toxicology · doi:10.3109/10408444.2010.529105 · Cited by 365
New views on cellular uptake and trafficking of manufactured nanoparticles
Treuel, L., Jiang, X., & Nienhaus, G. U. (2013) · Journal of The Royal Society Interface · doi:10.1098/rsif.2012.0939 · Cited by 362
Health and Ecosystem Risks of Graphene
Hu, X., & Zhou, Q. (2013) · Chemical Reviews · doi:10.1021/cr300045n · Cited by 360
Hadjidemetriou, M., Al-Ahmady, Z., Mazza, M., Collins, R. F., Dawson, K., & Kostarelos, K. (2015) · ACS Nano · doi:10.1021/acsnano.5b03300 · Cited by 358
“fibrillation process has been mainly investigated in solutions ofmodel-amyloidogenic proteins, under controlled conditions that promote protein aggregation.(46) 49”
BackgroundSelf-citationEnhanced optical asymmetry in supramolecular chiroplasmonic assemblies with long-range order
Lu, J., Xue, Y., Bernardino, K., Zhang, N.-N., Gomes, W. R., Ramesar, N. S., Liu, S., Hu, Z., Sun, T., de Moura, A. F., et al. (2021) · Science · doi:10.1126/science.abd8576 · Cited by 358
Wiesner, M. R., Lowry, G. V., Jones, K. L., Hochella, Jr., Di Giulio, R. T., Casman, E., & Bernhardt, E. S. (2009) · Environmental Science & Technology · doi:10.1021/es803621k · Cited by 350
A Predictive Toxicological Paradigm for the Safety Assessment of Nanomaterials
Meng, H., Xia, T., George, S., & Nel, A. E. (2009) · ACS Nano · doi:10.1021/nn9005973 · Cited by 344
Impact of the Nanoparticle–Protein Corona on Colloidal Stability and Protein Structure
Gebauer, J. S., Malissek, M., Simon, S., Knauer, S. K., Maskos, M., Stauber, R. H., Peukert, W., & Treuel, L. (2012) · Langmuir · doi:10.1021/la301104a · Cited by 336
Williams, T. L., & Serpell, L. C. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08228.x · Cited by 335
Silver nanoparticle protein corona and toxicity: a mini-review
Durán, N., Silveira, C. P., Durán, M., & Martinez, D. S. T. (2015) · Journal of Nanobiotechnology · doi:10.1186/s12951-015-0114-4 · Cited by 333
Yang, W., Wang, L., Mettenbrink, E. M., DeAngelis, P. L., & Wilhelm, S. (2021) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-032320-110338 · Cited by 327
Rivera Gil, P., Oberdörster, G., Elder, A., Puntes, V., & Parak, W. J. (2010) · ACS Nano · doi:10.1021/nn1025687 · Cited by 314
Reduced Cytotoxicity of Graphene Nanosheets Mediated by Blood-Protein Coating
Chong, Y., Ge, C., Yang, Z., Garate, J. A., Gu, Z., Weber, J. K., Liu, J., & Zhou, R. (2015) · ACS Nano · doi:10.1021/nn5066606 · Cited by 314
Biosafety and Bioapplication of Nanomaterials by Designing Protein–Nanoparticle Interactions
Yang, S., Liu, Y., Wang, Y., & Cao, A. (2013) · Small · doi:10.1002/smll.201201492 · Cited by 296
Park, S. J. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s254808 · Cited by 293
Controlling the Stealth Effect of Nanocarriers through Understanding the Protein Corona
Schöttler, S., Landfester, K., & Mailänder, V. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201602233 · Cited by 291
Nanoparticle–protein corona complexes govern the biological fates and functions of nanoparticles
Gunawan, C., Lim, M., Marquis, C. P., & Amal, R. (2014) · Journal of Materials Chemistry B · doi:10.1039/c3tb21526a · Cited by 277
Dual Effect of Amino Modified Polystyrene Nanoparticles on Amyloid β Protein Fibrillation
Cabaleiro-Lago, C., Quinlan-Pluck, F., Lynch, I., Dawson, K. A., & Linse, S. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn900027u · Cited by 275
Self-citationYoo, S. I., Yang, M., Brender, J. R., Subramanian, V., Sun, K., Joo, N. E., Jeong, S., Ramamoorthy, A., & Kotov, N. A. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201007824 · Cited by 269
Validation of an LDH assay for assessing nanoparticle toxicity
Han, X., Gelein, R., Corson, N., Wade-Mercer, P., Jiang, J., Biswas, P., Finkelstein, J. N., Elder, A., & Oberdörster, G. (2011) · Toxicology · doi:10.1016/j.tox.2011.06.011 · Cited by 268
The viral protein corona directs viral pathogenesis and amyloid aggregation
Ezzat, K., Pernemalm, M., Pålsson, S., Roberts, T. C., Järver, P., Dondalska, A., Bestas, B., Sobkowiak, M. J., Levänen, B., Sköld, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10192-2 · Cited by 209
Effect of Nanoparticles on Protein Folding and Fibrillogenesis
Fei, L., & Perrett, S. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10020646 · Cited by 198
“surface plasmon resonance (SPR) has shown that β2-microglobulin forms multiple layers on N-isopropylacrylamide/N-tert-butylacrylamide (NIPAM/BAM) nanoparticles, which means a high local protein concentration favorable for amyloid fibril formation is produced [33,34].”
BackgroundCalderón-Garcidueñas, L., & Ayala, A. (2022) · Environmental Science & Technology · doi:10.1021/acs.est.1c04706 · Cited by 180
Multiple aspects of the interaction of biomacromolecules with inorganic surfaces
Fenoglio, I., Fubini, B., Ghibaudi, E. M., & Turci, F. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.08.001 · Cited by 176
“Nevertheless in discussing the alteration of surface properties of the protein–solid particle system is worth to mention here that NPs have been reported to influence protein fibrillation processes [136–138].”
BackgroundThe potential of protein–nanomaterial interaction for advanced drug delivery
Peng, Q., & Mu, H. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.041 · Cited by 134
Burke, K. A., Yates, E. A., & Legleiter, J. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00017 · Cited by 127
“Aβ(1–40) and Aβ(1–42) adsorption to Teflon particles increased aggregation and fibrillogenesis (Linse et al., 2007).”
BackgroundFibril fragmentation in amyloid assembly and cytotoxicity: When size matters
Xue, W.-F., Hellewell, A. L., Hewitt, E. W., & Radford, S. E. (2010) · Prion · doi:10.4161/pri.4.1.11378 · Cited by 117
Self-citationAlternative in vitro assays in nanomaterial toxicology
Hartung, T., & Sabbioni, E. (2011) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.153 · Cited by 84
Cui, Z., Bu, W., Fan, W., Zhang, J., Ni, D., Liu, Y., Wang, J., Liu, J., Yao, Z., & Shi, J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.056 · Cited by 83
Specific Domains of Aβ Facilitate Aggregation on and Association with Lipid Bilayers
Yates, E. A., Owens, S. L., Lynch, M. F., Cucco, E. M., Umbaugh, C. S., & Legleiter, J. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.03.022 · Cited by 41
Unveiling the theranostic potential of SPIONs in Alzheimer's disease management
Aminyavari, S., Afshari, A. R., Ahmadi, S. S., Kesharwani, P., Sanati, M., & Sahebkar, A. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.09.022 · Cited by 5
Metadata
- Authors
- Linse, S., Cabaleiro-Lago, C., Xue, W.-F., Lynch, I., Lindman, S., Thulin, E., Radford, S. E., & Dawson, K. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2007-05-22
- Volume
- 104
- Issue
- 21
- Pages
- 8691-8696
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1991659188
- Cited by
- 886
- References
- 50
- FWCI
- 14.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.